Showing results (61-70 of 402) with videos related to

Sort By:
Pageof 41
Clinical Kidney Journal|March 3, 2023
PLEX in AAV-GN: insights from the meta-analysis results and impact on remission induction treatment recommendationsMarta Casal Moura, Cynthia S Crowson, Ulrich Specks, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 29, 2011
Fibrillary glomerulonephritis: a report of 66 cases from a single institutionSamih H Nasr, Anthony M Valeri, Lynn D Cornell, et al.
Kidney International Reports|December 22, 2025
Mass Spectrometry of Minimal Change Disease and Focal Segmental GlomerulosclerosisFernando C Fervenza, Maria J Vargas-Brochero, Hanna Debiec, et al.
Nephron. Clinical Practice|December 17, 2010
Rituximab in ANCA-associated vasculitis: fad or fact?Fernando C Fervenza
Clinical Journal of the American Society of Nephrology : CJASN|July 27, 2013
A patient with nephrotic-range proteinuria and focal global glomerulosclerosisFernando C Fervenza
Kidney International|June 8, 2025
Phospholipase A2 receptor-positive membranous nephropathy detected by laser microdissection and mass spectrometry in patients negative by immunofluorescence for phospholipase A2 receptor on kidney biopsyLadan Zand, Ilario Russo, Maria J Vargas-Brochero, et al.
Kidney International|December 14, 2012
Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complementSanjeev Sethi, Fernando C Fervenza, Yuzhou Zhang, et al.
Pediatric Nephrology (Berlin, Germany)|January 14, 2016
Discontinuation of dialysis with eculizumab therapy in a pediatric patient with dense deposit diseaseCheryl L Tran, Sanjeev Sethi, David Murray, et al.
Journal of the American Society of Nephrology : JASN|September 7, 2014
IgD heavy-chain deposition disease: detection by laser microdissection and mass spectrometryVirginie Royal, Patrick Quint, Martine Leblanc, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 10, 2014
A pilot study to determine the dose and effectiveness of adrenocorticotrophic hormone (H.P. Acthar® Gel) in nephrotic syndrome due to idiopathic membranous nephropathyMichelle A Hladunewich, Daniel Cattran, Laurence H Beck, et al.
Pageof 41